Analyst Ratings for Kala Pharmaceuticals (KALA)
KALA Rating Summary
KALA Price Target Summary
- Highest: $22.00 (Wedbush)
- Lowest: $21.00 (H.C. Wainwright)
- Average: $21.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$21.50 (+247.9%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/30/2022 | JPMorgan | Christopher Neyor | Downgrade | Underweight (Neutral) |
1.50 (N/A) |
1.75 (6.18) |
253.14% | Details |
| 12/15/2021 | Wedbush » Updated 11/14/2023 |
Andreas Argyrides | New Coverage | Outperform (N/A) |
22.00 (39.00) |
1.45 (6.18) |
326.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
